One could envision that the synthetic lethality between mitochondrial uncoupling and p53 loss would confer niclosamide tumor-suppressor functions by establishing a metabolic environment favoring the outgrowth of p53 wild-type cells. This evidence concerns the gene TP53 and neoplasm.